Ly6G6d inhibitors represent a class of chemical compounds that target and modulate the activity of the Ly6G6d protein, a member of the Ly6/uPAR family. These proteins are part of a larger superfamily of surface molecules, known for their role in cell signaling, adhesion, and immune response modulation. The Ly6/uPAR proteins share structural homology in their characteristic three-finger fold architecture, which is formed by a conserved disulfide-bonded loop structure. This unique fold is critical for their interactions with various ligands and receptors, making them key modulators in numerous cellular pathways. Ly6G6d is a lesser-characterized protein within this family, though it is known to be involved in complex cellular processes like cell migration, immune cell signaling, and potentially in modulating receptor-ligand interactions on the cell surface. Inhibitors of Ly6G6d disrupt these interactions, offering valuable insights into its role in cell biology.
Structurally, Ly6G6d inhibitors are designed to bind to the active or regulatory sites on the Ly6G6d protein, thereby interfering with its normal function. These inhibitors can be small molecules, peptides, or other types of chemical modulators. Their binding often induces conformational changes in the protein, which can lead to alterations in its ability to interact with other cellular components. This structural interference helps elucidate the mechanistic pathways Ly6G6d participates in, particularly those involving cell surface signaling. The study of Ly6G6d inhibitors provides a platform for further understanding of the broader Ly6/uPAR protein family's regulatory roles in the immune system and cellular communication, particularly in contexts where precise cell signaling is required for proper cellular responses.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Inhibitor of calcineurin, which can modulate T-cell activation pathways that may involve Ly6G6d. | ||||||
FK-506 | 104987-11-3 | sc-24649 sc-24649A | 5 mg 10 mg | $78.00 $151.00 | 9 | |
Another calcineurin inhibitor, affecting T-cell signaling and potentially impacting Ly6G6d activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibitor of mTOR, which can influence T-cell differentiation and might affect Ly6G6d. | ||||||
Lenalidomide | 191732-72-6 | sc-218656 sc-218656A sc-218656B | 10 mg 100 mg 1 g | $50.00 $374.00 $2071.00 | 18 | |
Modulator of the ubiquitin-proteasome pathway, which can affect protein levels, including Ly6G6d. | ||||||
Ibrutinib | 936563-96-1 | sc-483194 | 10 mg | $156.00 | 5 | |
Bruton's tyrosine kinase inhibitor, can affect B-cell receptor signaling that may involve Ly6G6d. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Src-family kinase inhibitor, potentially modulating signaling pathways where Ly6G6d is involved. | ||||||
Leflunomide | 75706-12-6 | sc-202209 sc-202209A | 10 mg 50 mg | $20.00 $83.00 | 5 | |
Inhibitor of dihydroorotate dehydrogenase, affecting pyrimidine synthesis and lymphocyte function. | ||||||
FTY720 | 162359-56-0 | sc-202161 sc-202161A sc-202161B | 1 mg 5 mg 25 mg | $33.00 $77.00 $120.00 | 14 | |
S1P receptor modulator, could affect lymphocyte recirculation, potentially impacting Ly6G6d. | ||||||